XEROX HOLDINGS CORPORATION
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $7.02B | $6.22B | $6.89B | $7.11B | $7.04B | $7.02B | $9.07B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | $275.0M | $375.0M | — | — |
| Gross Margin | — | — | — | — | 3.9% | 5.3% | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $1.65B | $1.54B | $1.70B | $1.76B | $1.72B | $1.85B | $2.09B |
| Operating Income | — | $-488.0M | $-1.22B | $-28.0M | $-129.0M | $-268.0M | $467.0M | $1.06B |
| Operating Margin | — | -6.9% | -19.5% | -0.4% | -1.8% | -3.8% | 6.7% | 11.7% |
| Interest Expense | — | $334.0M | $225.0M | $198.0M | $199.0M | $207.0M | $215.0M | $236.0M |
| Pretax Income | — | — | — | — | $-328.0M | $-475.0M | $252.0M | $822.0M |
| Income Tax Expense | — | $541.0M | $105.0M | $-29.0M | $-3.0M | $-17.0M | $64.0M | $179.0M |
| Net Income | — | $-1.03B | $-1.32B | $1.0M | $-322.0M | $-455.0M | $192.0M | $1.35B |
| Net Margin | — | -14.7% | -21.2% | 0.0% | -4.5% | -6.5% | 2.7% | 14.9% |
| EPS (Basic) | — | $-8.25 | $-10.75 | $-0.09 | $-2.15 | $-2.56 | $0.85 | $6.03 |
| EPS (Diluted) | — | $-8.25 | $-10.75 | $-0.09 | $-2.15 | $-2.56 | $0.84 | $5.80 |
| Shares Outstanding (Basic) | 128.6M | 126.5M | 124.2M | 149.1M | 156.0M | 183.2M | 209.0M | 222.0M |
| Shares Outstanding (Diluted) | 128.6M | 126.5M | 124.2M | 149.1M | 156.0M | 183.2M | 209.0M | 222.0M |
| Dividends Per Share | — | $0.20 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 |